Asianet Newsable on MSN
BIIB stock ends 3% higher — why this strategist picks Biogen over other biotech peers
Jay Woods recommended investing in the BioTech ETF and Biogen in particular within the ETF.
Monash University's Kate Strayer-Benton and Andrew R. Snyder, PhD. join the program live from Bio 2026 in San Diego, where ...
NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...
Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International ...
Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.
"First they crawled... now they seem to be evolving through information exchange." 🧟 Evolving zombies! Well Go USA has ...
The fireside chat is scheduled for 1:00 p.m. ET on June 30, 2026, and will be moderated by Matthew Caufield, Senior Research Healthcare Analyst at H.C. Wainwright & Co. FibroBiologics will be ...
Dr. Jessica Maloh to lead Continuing Medical Education session 'The Biology of Breakouts”; Codex Labs to feature its plant-biotech acne portfolio and Decode.Me integrative dermatology platform ...
Shares in Clarity Pharmaceuticals Ltd (ASX: CU6) were trading more than 10% higher on good news about its prostate cancer ...
Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price ...
10d
UPDATE: “…complete disregard for the dignity of the deceased,” said CBI in Davis Mortuary arrests
Watch previous coverage above. At 1:30 p.m. on Thursday, FOX21 News will livestream a press conference in the video player ...
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results